↓ Skip to main content

Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months

Overview of attention for article published in Cochrane database of systematic reviews, December 2016
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (94th percentile)
  • High Attention Score compared to outputs of the same age and source (80th percentile)

Mentioned by

twitter
53 tweeters
facebook
8 Facebook pages
wikipedia
2 Wikipedia pages

Citations

dimensions_citation
20 Dimensions

Readers on

mendeley
143 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Zinc supplementation for the prevention of pneumonia in children aged 2 months to 59 months
Published in
Cochrane database of systematic reviews, December 2016
DOI 10.1002/14651858.cd005978.pub3
Pubmed ID
Authors

Zohra S Lassi, Anoosh Moin, Zulfiqar A Bhutta

Abstract

Pneumonia is a leading cause of morbidity and mortality in children younger than five years of age. Most deaths occur during infancy and in low-income countries. Daily zinc supplements have been reported to prevent acute lower respiratory tract infection (LRTI) and reduce child mortality. This is an update of a review first published in 2010. To evaluate the effectiveness of zinc supplementation in the prevention of pneumonia in children aged two to 59 months. We searched CENTRAL (Issue 21 October 2016), MEDLINE (1966 to October 2016), Embase (1974 to October 2016), LILACS (1982 to October 2016), CINAHL (1981 to October 2016), Web of Science (1985 to October 2016) and IMSEAR (1980 to October 2016). Randomised controlled trials (RCTs) evaluating zinc supplementation for the prevention of pneumonia in children aged from 2 months to 59 months. Two review authors independently assessed trial quality and extracted data. We did not identify any new studies for inclusion in this update. We included six studies that involved 5193 participants.Analysis showed that zinc supplementation reduced the incidence of pneumonia by 13% (fixed-effect risk ratio (RR) 0.87; 95% confidence interval (CI) 0.81 to 0.94, six studies, low-quality evidence) and prevalence of pneumonia by 41% (random-effects RR 0.59; 95% CI 0.35 to 0.99, one study, n = 609, low-quality evidence). On subgroup analysis, we found that zinc reduced the incidence of pneumonia defined by specific clinical criteria by 21% (i.e. confirmation by chest examination or chest radiograph) (fixed-effect RR 0.79; 95% CI 0.0.71 to 0.88, four studies, n = 3261), but had no effect on lower specificity pneumonia case definition (i.e. age-specific fast breathing with or without lower chest indrawing) (fixed-effect RR 0.95; 95% CI 0.86 to 1.06, four studies, n = 1932). Zinc supplementation in children is associated with a reduction in the incidence and prevalence of pneumonia.

Twitter Demographics

The data shown below were collected from the profiles of 53 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 143 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Mexico 1 <1%
Unknown 142 99%

Demographic breakdown

Readers by professional status Count As %
Student > Master 32 22%
Student > Bachelor 26 18%
Researcher 18 13%
Student > Ph. D. Student 15 10%
Student > Postgraduate 8 6%
Other 27 19%
Unknown 17 12%
Readers by discipline Count As %
Medicine and Dentistry 64 45%
Nursing and Health Professions 19 13%
Agricultural and Biological Sciences 8 6%
Social Sciences 8 6%
Biochemistry, Genetics and Molecular Biology 4 3%
Other 14 10%
Unknown 26 18%

Attention Score in Context

This research output has an Altmetric Attention Score of 38. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 July 2019.
All research outputs
#501,412
of 14,328,195 outputs
Outputs from Cochrane database of systematic reviews
#1,444
of 10,950 outputs
Outputs of similar age
#20,052
of 378,841 outputs
Outputs of similar age from Cochrane database of systematic reviews
#29
of 147 outputs
Altmetric has tracked 14,328,195 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,950 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 21.8. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 378,841 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 94% of its contemporaries.
We're also able to compare this research output to 147 others from the same source and published within six weeks on either side of this one. This one has done well, scoring higher than 80% of its contemporaries.